Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a mid-cap US stock, returning 14,421%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 14,420.96% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Abivax SA American Depositary Shares (ABVX) | 1,094.89% |
TMC the metals (TMC) | 700% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 489.16% |
Centrus Energy (LEU) | 439.43% |
Opendoor Technologies (OPEN) | 422.46% |
Forward Industries (FORD) | 403.07% |
Mercurity Fintech Holding Inc ADR (MFH) | 352.92% |
Ondas (ONDS) | 350.4% |
GRAIL, LLC (GRAL) | 308.47% |
Ramaco Resources (METC) | 308.25% |
ViaSat (VSAT) | 305.11% |
Planet Labs PBC (PL) | 281.42% |
Sandisk (SNDK) | 276.16% |
Celcuity LLC (CELC) | 274.43% |
Cipher Mining (CIFR) | 263.64% |
Cidara Therapeutics (CDTX) | 263.37% |
Applied Digital (APLD) | 255.92% |
Sibanye Gold Ltd ADR (SBSW) | 254.84% |
DRDGOLD Limited ADR (DRD) | 245.19% |
American Bitcoin (ABTC) | 243.22% |
Energy Fuels (UUUU) | 242.86% |
Uniqure (QURE) | 235.97% |
SSR Mining (SSRM) | 233.95% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
